The Journal of Dental Panacea

Online ISSN: 2348-8727

CODEN : JDP

The Journal of Dental Panacea (JDP) open access, peer-reviewed quarterly journal, Publish quarterly as Open Access (OA).  Vision of this journal  for better dissemination of knowledge, Journal will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in JDP. Manuscripts must be prepared in accordance with “Uniform requirements” of the The Journal of Dental Panacea as more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 457

PDF Downloaded: 169


Get Permission Sophia, Sebastian, Linda Christabel. S, Merrylda Claribel. S, and Devi: The management of dental pain using pharmaceutical drugs-A review


Introduction

Pain is a subjective symptom that indicates a need to act quickly, and it is frequently coupled with other subjective feelings like fear, anger, and discomfort. Different patient-related variables influence the nature and degree of pain expression. Gender, age, physiological parameters, substance misuse history, neuropathic and other disease, and psychological profile of individual people are all elements that influence the patient's interpretation of pain.1, 2 "A painful sensory and emotional experience related with, or mimicking, actual or potential tissue injury," according to the International Association for the Study of Pain.

Following various interventional procedures and dental illnesses, dental pain (toothache or odontalgia) is a typical subjective complaint of dental patients. Dental discomfort is one of the most prevalent reasons for people seeking emergency dental care in the United States (about 12 %).3 Odontogenic pain is a multi-step process that begins with dental tissue destruction and is accompanied by a variety of neural stimuli as a result of neurovascular, neuroinflammation, and morphologic reactions.4, 2

When it comes to prescription rates, clinical efficacy, cost-effectiveness, and safety profile, analgesics are one of the most important pharmacological classes in dentistry practise. There are various approaches to developing treatment algorithms and guidelines for dental pain therapy based on this amount of priority in dental clinical practise. Nonetheless, prescribing analgesic medicines for dental indications is fraught with difficulties, lowering therapeutic success and raising the risk of major side effects. 2

In this review, the management of dental pain using pharmaceutical drugs is explained.

Odontogenic pain

Pain caused in tooth region is known as Odontogenic pain. It is caused mainly because of the following causes: 5

  1. Pulpal Dentinal hypersensitivity Pulp disease (pulpitis)

  2. Pathology in periapical region (acute abscess)

  3. Gum/periodontal disease

  4. Cracked tooth syndrome

  5. Dental trauma

Classification of Drugs

Classification of analgesics is broadly classified as Opioid analgesics and Non-opioid and non-steroidal (NSAIDS)

Opioid analgesics: 6, 7

  1. Natural opium alkaloids:

    1. Morphine

    2. Codeine

  2. Semisynthetic opiates:

    1. Diacetylmorphine (Heroin)

    2. Pholcodeine

  3. Synthetic opioids:

    1. Pethidine (Meperidine)

    2. Fentanyl, Alfentanil, Sufentanil, Remifentanil

    3. Methadone

    4. Dextropropoxyphene

    5. Tramadol

Non-opioid and non-steroidal analgesics (NSAIDS):8

Non selective COX inhibitors

  1. Salicylates:

    1. Aspirin

  2. Propionic acid derivatives:

    1. Ibuprofen

    2. Naproxen

    3. Ketoprofen

    4. Flurbiprofen

  3. Fenamate:

    1. Mephenamic acid

  4. Enolic acid derivatives:

    1. Piroxicam

    2. Tenoxicam

  5. Acetic acid derivatives:

    1. Ketorolac

    2. Indomethacin

    3. Nabumetone

  6. Pyrazolone derivatives:

    1. Phenylbutazone

    2. Oxyphenylbutazone

  7. Selective COX-2 inhibitors:

    1. Celecoxib

    2. Etoricoxib

    3. Parecoxib

  8. Preferential COX-2 inhibitors:

    1. Nimesulide

    2. Diclofenac

    3. Aceclofenac

    4. Meloxicam

    5. Etodolac

Analgesic - antipyretics with poor anti-inflammatory action

  1. Para aminophenol derivative:

    1. Paracetamol (Acetaminophen)

  2. Pyrazolone derivatives:

    1. Metamizole((Dipyrone)

    2. Propyphenazone

  3. Benzoxazocine derivative:

    1. Nefopam

MOA of Analgesics

NSAIDS

The cyclo-oxygenase enzyme has two structurally different variants (COX-l and COX-2). COX-1 is a naturally occurring protein in normal cells, whereas COX-2 is increased in inflammatory cells. The most plausible mechanism of action for NSAID-mediated analgesia is inhibition of COX-2 activity. Some NSAIDs block the lipoxygenase pathway, which can lead to allogenic metabolites being produced. NSAIDs' interference with G-protein-mediated signal transduction could be the basis of an analgesic mechanism unrelated to prostaglandin production inhibition. There's a growing body of evidence that NSAIDs have a central mechanism of action that works in tandem with the peripheral mechanism. This impact could be caused by interfering with prostaglandin production in the CNS. Endogenous opioid peptides or inhibition of serotonin release could also be involved in the central action (5-hydroxytryptamine; 5-HT). A mechanism involving excitatory amino acid inhibition or activation of N-methyl-D-aspartate receptors has also been proposed. 9

Opioids

The most often prescribed painkillers are opioids and nonsteroidal anti-inflammatory medications (NSAIDs). By engaging with mu, delta, or kappa opioid receptors, opioids mimic the activities of endogenous opioid peptides. The opioid receptors are linked to G1 proteins, therefore opioids have primarily inhibitory effects. They open calcium-dependent inwardly-rectifying potassium channels while closing N-type voltage-operated calcium channels. Hyperpolarization and a decrease in neural excitability ensue as a result of this. They also reduce intracellular cAMP, which regulates nociceptive neurotransmitter release (e.g. substance P). The main mechanism of analgesic and anti-inflammatory effects of NSAIDs is inhibition of prostaglandin synthesis by cyclooxygenase. Aspirin inhibits cyclo-oxygenase irreversibly, while other NSAIDs inhibit it reversibly. 10

Commonly used drugs for dental pain:11

Acetaminophen is an antipyretic analgesic used to treat mild to moderate pain. It has no anti-inflammatory properties. Excessive doses can cause permanent liver damage, while long-term use can cause kidney toxicity. Paracetamol is a good example.

NSAIDs - Have analgesic, antipyretic, and anti-inflammatory properties. NSAIDs have been shown to be effective in the treatment of a variety of dental pains. Nonselective NSAIDs inhibit both COX-1 and COX-2, resulting in GI bleeding and ulceration. Aspirin and ibuprofen are two examples.

Opioids - Opioid analgesia is caused by opioid receptor activation, which inhibits neuronal activity. In the treatment of acute dental pain, opioids are usually coupled with acetaminophen. Morphine and tramadol are two examples.

Factors affecting selection of analgesics for dental pain: 12, 2

The selection of analgesic medicines in the treatment of dental pain is influenced by a number of factors, including:

  1. Mechanism of pathophysiological pain: This is a determining element in analgesic selection. Cancer metastases, postoperative dental pain, nerve root infiltration, neuropathic pain, and other mechanisms are among them.

  2. The age of the patient: The choice of analgesic is also influenced by the patient's age. Analgesics are administered differently in youngsters and the elderly than in adults. Due to immature metabolism processes, the use of a number of analgesics in children is restricted. Due to diminished potential of metabolism and/or excretion, which reflects in pharmacokinetics and pharmacodynamics of medications, the aged frequently require a dose restriction of analgesics.

  3. Administration route: The analgesic's bioavailability and pharmaceutical formulation are determined by the patient's overall health, disease features, and bioavailability. Analgesics should be taken orally whenever possible. Pharmaceutical formulations with controlled release are better for chronic pain than those with rapid release.

  4. Patients-related features. Several factors can influence the effectiveness of analgesic treatment in dental patients. Dental physicians should think about the placebo effect carefully. The potential renal and hepatic toxic effects, as well as gastrointestinal disturbances that may affect the pharmacokinetic and safety profile, should be addressed first by dental experts.

Management of Dental pain in Adults

In patients who are adults, Pain management in dentistry is usually a surprise and is largely dependent on the particular patient's sensitivity to pain, the patient's expectations, the pathophysiological mechanism of pain, and the choice of analgesic medicines. Pain reduction is a critical precondition for interventional dentistry therapy because it establishes a trusting and comfortable relationship between patients and their dentist. 13 Almost all dental operations are accompanied by pain of varying severity, nature, and duration, and pain management is an important element of dental treatment, whether it is done before or after the surgery. 14 In order to achieve a good clinical outcome and a successful dental clinical therapy, effective pain treatment is required during dentistry healthcare. The use of local anaesthetic ensures the control of patient discomfort during the patient preparation phase, prior to the commencement of dentistry procedures.15 Clinical evidence demonstrates that local anaesthetic relieves pain during the intraoperative dental phase and quickly relieves postoperative pain, therefore dentists should consider appropriate pain management at all stages of dental treatment. Due to prostaglandins' interaction with tetrodotoxin-resistant receptors, which lowers nerve responses to local anaesthesia, the effect of local anaesthetic is lessened in the oral pathological process.16 Dental doctors should focus on the disease, the patient, and lastly the various nonpharmacological and pharmacologically effective therapy choices for effective dental pain management. To comprehend the cause of disease and anticipate the patient's health status, the dental practitioner should first analyse the pathological process of dental tissue. Determining the genesis of the disease process, particularly the final inflammatory response, is critical.17 Premedication with NSAIDs such as ibuprofen or indomethacin has been shown to considerably increase the level of alveolar nerve block anaesthesia in dental treatments (78 %and 62 %, respectively) when compared to placebo (32 %).18 A pain response develops throughout the healing process of soft tissue injuries, necessitating pain treatment techniques. Preoperative administration of medication, including analgesic drugs, is suggested in dental surgical procedures to reduce postoperative discomfort and the need for postoperative painkiller. 118 Analgesics to Alternative Therapies for Pain Relief The dynamic process of creating a logical treatment map, which is built by the methodology of conceptualization to visualise the relationship between patient symptoms, dental interventions, therapeutic treatment, and the patient's needs and expectations, is the foundation of an effective dental pain treatment strategy. Furthermore, there is misinformation accessible claiming that naproxen sodium has higher analgesic efficacy to ibuprofen at post-dose intervals of 1 to 12 hours. 19, 20, 21 Para-aminophenol derivatives, such as paracetamol, are useful analgesics for use in dentistry (acetaminophen). Individual paracetamol administration is only suggested in moderate cases of dental pain when NSAIDs are contraindicated. Otherwise, clinical evidence suggests that ibuprofen 200–512 mg is preferable to paracetamol 600–1000 mg in reducing postoperative pain. The usage of a combination of ibuprofen and paracetamol as a pain reliever is a novel method. When taken 6 hours after dental intervention, this combination is more effective than solo analgesics. The most common doses of respective analgesics administered in clinical practise are 400 mg for ibuprofen and 1000 mg for paracetamol, according to the data. 22 When solo NSAID analgesics or a combination of NSAID and paracetamol are ineffective, a combination of opioids and NSAIDs is indicated. The analgesic impact of this medication combination is greater than twice the dose of either analgesic when taken separately. 23, 2

Management of Dental Pain in Children

Effective pain management is a normal routine method in clinical paediatric care and is required in the modern paradigm of health care. It is widely believed that the underlying mechanism of pain in infants and children is very similar to that in adults, with the exception of neonates, who have certain physiological changes in pain, such as slower and less precise pain conduction but no major abnormalities in pain perception. 24 Over the previous two decades, modern pain management for children has made significant progress in terms of medical problems, surgical interventions, and the postoperative period. The interventional pharmacological and nonpharmacological approaches to advanced pain treatment are the two primary avenues. NSAIDs and other analgesics administered via various routes of administration (i.v. bolus administration, continuous infusion, rectal, transdermal, and other routes of administration); local anaesthetics, epidural anaesthesia, and peripheral nerve blockade are all part of the interventional pharmacological approach. Breathing techniques, hypnosis, transcutaneous electrical nerve stimulation, guided imagery, acupuncture, relaxation, and other nonpharmacological measures include health education for children and psychological approaches to release the perception of fear and other behavioural problems in children patients, as well as breathing techniques, hypnosis, transcutaneous electrical nerve stimulation, guided imagery, acupuncture, relaxation, and other techniques to relieve pain.25 Children's pain management strategies are based on numerous principles that reflect the distinctions in pain treatment between children and adults. Preventing pain should be the goal of pain relief strategies, as this provides higher treatment success before invasive procedures. Typically, this begins with pre-planning the kid and family in order to lessen fear and anxiety before to intervention, as well as the use of patient-controlled analgesia (PCA). In the case of significant surgical procedures, the treatment of anticipated pain in children can be continued with oral analgesics, depending on the patient's needs. 2

Significant Drug Interactions of Analgesics

When NSAIDs are used with the anticoagulant and antiplatelet effects of warfarin and clopidrogel, substantial interactions occur, resulting in enhanced effects and an increased risk of bleeding. Acetaminophen is an appropriate choice in this case, but only at the lowest feasible dose and for short-term treatment. In contrast to diclofenac or acetaminophen, which had no effect on aspirin's antiplatelet activity, ibuprofen use in patients taking cardio protective aspirin did not interfere with its antiplatelet activity, despite studies showing reduced cardio protective benefits and increased gastrointestinal risk, in contrast to diclofenac or acetaminophen, which had no effect on aspirin's antiplatelet activity.26 Furthermore, individuals receiving daily aspirin for cardiovascular disease prevention should avoid chronic ibuprofen usage, and the FDA recommends taking ibuprofen at least 8 hours before or after the immediate release of aspirin to avoid potential platelet function interactions. 27 The use of NSAIDs in combination with warfarin or corticosteroids may increase the risk of gastrointestinal bleeding. When used in conjunction with biphosphonates, they also increase the risk of gastrointestinal ulcers. Coadministration of NSAIDs enhances the effects of antidiabetic sulfonylureas. With the use of NSAIDs, there is a decrease in methotrexate renal extraction, which can lead to toxicity. Lithium serum concentrations are also elevated, necessitating the use of a non-NSAID analgesic. Fluconazole has also been proven to boost celecoxib levels by inhibiting its metabolism. NSAIDs interact with ACE inhibitors, diuretics, Ca-channel beta Blockers, and beta-blockers, resulting in reduced antihypertensive effects. Short-term use does not represent a significant risk in healthy people, but if the medication is to be continued for a long time in hypertensive patients, especially the elderly, cautious selection and constant monitoring is essential. Antacids have been proven to reduce the effects of NSAIDs. In addition, NSAIDs have been observed to interact with SSRIs (selective serotonin reuptake inhibitors) to increase the risk of bleeding, especially upper gastrointestinal and postoperative bleeding. 28, 29 There are extremely few medication interactions with acetaminophen. As a metabolic inducer, carbamazepine may lower acetaminophen drug levels. When used with alcohol or medicines that affect the liver, the risk of liver toxicity increases. Dental practitioners should be aware of these interactions and utilise analgesic medication therapy in carefully researched combinations and within the dosage or interval limits. They should also avoid them when there is a higher risk of toxicity.30, 31 Antipsychotics (phenothiazines), which improve their hypotensive impact, and CYP2D6 inhibitors (cimetidine, chlorpheniramine, fluoxetine, and quinidine), which reduce their effects, including hydrocodone, are examples of narcotic analgesic interactions. When administered with morphine, oxycodone, or methadone, inhibitors or inducers of CYP3A4 generate clinically relevant interactions by mediating opioid toxicity or impairing pain therapy. Furthermore, the effects of SSRIs and MAOIs are more closely linked to meperidine, methadone, tramadol, buprenorphine, oxycodone, hydrocodone, pentazocine, and fentanyl, all of which may contribute to the serotonin syndrome. Barbiturates may augment the sedative effects of other sedatives. Phenytoin also causes an increase in meperidine metabolism. Taking this into account, clinicians should be aware of and monitor patients for drug interactions, as well as strive to avoid polypharmacy if possible. 32, 33, 34, 2

Conclusion

Prescribing an analgesic for dental pain is a challenge indeed. The dentist should understand the origin of the dental pain by taking detailed case history and the medical history of the patient should be known to prevent drug interactions. In the aspect of drug, one should know the mechanism of action of the drug and the duration of action (half -life). Age of the patient should be considered for proper dosage. If the above factors are taken care of, dental pain relief of the patient will be achieved successfully.

Source of Funding

None.

Conflict of Interest

None.

References

1 

R L Fainsinger C Nekolaichuk P Lawlor N Hagen M Bercovitch M Fisch An international multicentre validation study of a pain classification system for cancer patientsEur J Cancer201046162896904

2 

S Krasniqi A Daci Analgesics Use in DentistryPain Relief - From Analg to Altern ther201710.5772/66600

3 

R Anderson DW Thomas Toothache stories': a qualitative investigation of why and how people seek emergency dental careCommunity Dental Health200320210611

4 

HO Trowbridge Review of dental pain-histology and physiologyJ Endod198612104455010.1016/S0099-2399(86)80197-2

5 

S D Setty J Classification N Vadivelu A Vadivelu AD Kaye Classification and epidemiology of orofacial pain Orofacial Pain: A Clinician's GuideSpringer201416

6 

PR Blakemore JD White Morphine, the Proteus of organic moleculesChem Commun2002115968

7 

H Pathan J Williams Basic opioid pharmacology: an updateBr J Pain201261116

8 

KD Tripathi Essentials Of Pharmacology For Dentistry, 3rd Edn.Jaypee Brothers Medical Publishers2016

9 

J N Cashman The mechanisms of action of NSAIDs in analgesiaDrugs1996525132310.2165/00003495-199600525-00004

10 

J G Bovill Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugsEuropean Journal of Anaesthesiology19971591510.1097/00003643-199705001-00003

11 

A Kumarswamy Multimodal management of dental pain with focus on alternative medicine: A novel herbal dental gelContemp Clin Dent2016721319

12 

K Hargreaves P V Abbott Drugs for pain management in dentistryAus Dent J2005504S142210.1111/j.1834-7819.2005.tb00378.x

13 

R E Walton AF Reader RE Walton M Torabinejad Local anesthesiaPrinciples and Practice of Endodontics, 3rd Edn.Philadelphia: W.B. Saunders Company200299117

14 

M Donaldson JH Goodchild Appropriate analgesic prescribing for the general dentistGeneral Dent20095842917

15 

SF Malamed Handbook of Local Anesthesia, 6th Edn.Published by Mosby, MO, USA2012432

16 

MA Henry KM Hargreaves Peripheral mechanisms of odontogenic painDent Clin North Am2007511194410.1016/j.cden.2006.09.007

17 

J P Rood S Pateromichelakis Inflammation and peripheral nerve sensitisationBr J Oral Surg1981191677210.1016/0007-117X(81)90023-8

18 

M Parirokh R Ashouri A R Rekabi N Nakhaee A Pardakhti S Askarifard The effect of premedication with ibuprofen and indomethacin on the success of inferior alveolar nerve block for teeth with irreversible pulpitisJ Endod201036914504

19 

M D Kulkarni M S Baig S A Hussaini S M Doifode Drug utilization pattern in OPD of government dental college and hospital Aurangabad Int J Basic Clin Pharmacol20132169705455/2319-2003.ijbcp20130113

20 

D G Kalyvas M Tarenidou Influence of nonsteroidal anti-inflammatory drugs on osseointegrationJ Oral Sci200850323946

21 

T A Kiersch S C Halladay M Koschik A double-blind, randomized study of naproxen sodium, ibuprofen and placebo in postoperative dental painClin Ther199215584554

22 

E Bailey HV Worthington A Van Wijk JM Yates P Coulthard Z Afzal Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom 134 Pain Relief - From Analgesics to Alternative Therapies teethCochrane Database Syst Rev2013121215510.1002/14651858.CD004624.pub2

23 

GL Wideman M Keffer E Morris RT Doyle Jr JG Jiang WT Beaver Analgesic efficacy of a combination of hydrocodone with Ibuprofen in postoperative painClin Pharmacol Ther1999651667610.1016/S0009-9236(99)70123-2

24 

Consensus statement for the prevention and management of pain in the newbornArch Pediatr Adolesc Med2001155217380

25 

Y S Shim AH Kim EY Jeon A So-Youn Dental fear & anxiety and dental pain in children and adolescents: a systemic reviewJ Dent Anesth Pain Med20151525361

26 

EP Branco ML Pinheiro MC Volpato ED De Andrade Analgesic choice in dentistry. Part I: the mechanism of actionBraz J Oral Sci200541476265

27 

N Moore C Pollack P Butkerait Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDsTher Clin Risk Manag20151110617510.2147/TCRM.S79135

28 

EV Hersh A Pinto PA Moore Adverse drug interactions involving common prescription and over-the-counter analgesic agentsClin Ther20072911247797

29 

Z Der Khatchadourian I Moreno-Hay R De Leeuw Nonsteroidal anti-inflammatory drugs and antihypertensives: how do they relate? Oral Surgery, Oral Medicine, Oral Pathology and Oral Ra Hersh EV, Moore PA. Adverse drug interactions in dentistryPeriodontology200046110942

30 

H Smith P Bruckenthal Implications of opioid analgesia for medically complicated patientsDrugs Aging201027541733

31 

PA Moore EV Hersh Principles of pain management in dentistryThe ADA Practical Guide to Substance Use Disorders and Safe Prescribing52014314610.1002/9781119062738.ch3

32 

A M Trescot Opioid pharmacology and pharmacokineticsControlled Substance Management in Chronic PainSpringer International PublishingUSA20164562

33 

A Kotlinska-Lemieszek P Klepstad D F Haugen Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review. Drug DesignDrug Des Devel Ther2015952556710.2147/DDDT.S86983

34 

R J Weinstock M P Johnson Review of top 10 prescribed drugs and their interaction with dental treatmentDent Clin North Am201660242134



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.

Article type

Review Article


Article page

106-111


Authors Details

Khumukcham Sophia, Shalini Maria Sebastian, Linda Christabel. S, Merrylda Claribel. S, Mutum Sangeeta Devi


Article History

Received : 25-05-2022

Accepted : 10-06-2022


Article Metrics


View Article As

 


Downlaod Files